Emerging research suggests that a decline in cerebrospinal fluid flow may be an overlooked risk factor in glaucoma development and progression.
Exploring how cerebrospinal fluid stagnation and optic nerve compartmentation contribute to toxicity in normal-tension glaucoma.
Discover how Aβ−3–40, a novel cerebrospinal fluid biomarker, is revolutionizing early Alzheimer's disease detection through advanced biochemical analysis.